NCT02500641 2019-06-21FORWARDMenarini International Operations Luxembourg SAPhase 4 Completed196 enrolled 9 charts
NCT00628628 2013-08-01Rasburicase in Patients at Risk for Tumor Lysis SyndromeM.D. Anderson Cancer CenterPhase 2 Completed82 enrolled 6 charts
NCT00230178 2010-01-12Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis SyndromeSanofiPhase 3 Completed280 enrolled 10 charts